Advertisement

Topics

Keratitis - Pipeline Review, H1 2015

05:01 EDT 8 Jun 2015 | BioPortfolio Reports

Recently added to the BioPortfolio report store, Keratitis - Pipeline Review, H1 2015 is a new report from Global Markets Direct published on 2015-04-28. This 70-page report is available in PDF from $2000.

Keratitis - Pipeline Review, H1 2015

Summary

Global Markets Direct’s, ‘Keratitis - Pipeline Review, H1 2015’, provides an overview of the Keratitis’s therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Keratitis, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Keratitis and special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Keratitis
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in the therapeutics development for Keratitis and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects
- A review of the Keratitis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Keratitis pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and…

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 5
Introduction 6
Global Markets Direct Report Coverage 6
Keratitis Overview 7
Therapeutics Development 8
Pipeline Products for Keratitis - Overview 8
Pipeline Products for Keratitis - Comparative Analysis 9
Keratitis - Therapeutics under Development by Companies 10
Keratitis - Therapeutics under Investigation by Universities/Institutes 11
Keratitis - Pipeline Products Glance 12
Clinical Stage Products 12
Early Stage Products 13
Keratitis - Products under Development by Companies 14
Keratitis - Products under Investigation by Universities/Institutes 15
Keratitis - Companies Involved in Therapeutics Development 16
Adamis Pharmaceuticals Corporation 16
Cellceutix Corporation 17
Dompe Farmaceutici S.p.A. 18
Lee's Pharmaceutical Holdings Limited 19
Peregrine Pharmaceuticals, Inc. 20
RegeneRx Biopharmaceuticals, Inc. 21
Sirnaomics, Inc. 22
The Medicines Company 23
Keratitis - Therapeutics Assessment 24
Assessment by Monotherapy Products 24
Assessment by Target 25
Assessment by Mechanism of Action 27
Assessment by Route of Administration 29
Assessment by Molecule Type 31
Drug Profiles 33
brilacidin tetrahydrochloride - Drug Profile 33
Product Description 33
Mechanism of Action 33
R&D Progress 33
C-31G - Drug Profile 35
Product Description 35
Mechanism of Action 35
R&D Progress 35
dipyridamole - Drug Profile 37
Product Description 37
Mechanism of Action 37
R&D Progress 37
IBN-1 - Drug Profile 38
Product Description 38
Mechanism of Action 38
R&D Progress 38
LQ-7 - Drug Profile 40
Product Description 40
Mechanism of Action 40
R&D Progress 40
moxifloxacin hydrochloride - Drug Profile 41
Product Description 41
Mechanism of Action 41
R&D Progress 41
PGN-632 - Drug Profile 42
Product Description 42
Mechanism of Action 42
R&D Progress 42
PIM-45 - Drug Profile 43
Product Description 43
Mechanism of Action 43
R&D Progress 43
Recombinant Human Nerve Growth Factor - Drug Profile 44
Product Description 44
Mechanism of Action 44
R&D Progress 44
RGN-259 - Drug Profile 45
Product Description 45
Mechanism of Action 45
R&D Progress 45
Small Molecules to Inhibit ATM for Herpes Keratitis - Drug Profile 47
Product Description 47
Mechanism of Action 47
R&D Progress 47
STP-601 - Drug Profile 48
Product Description 48
Mechanism of Action 48
R&D Progress 48
targocil - Drug Profile 49
Product Description 49
Mechanism of Action 49
R&D Progress 49
tigecycline - Drug Profile 50
Product Description 50
Mechanism of Action 50
R&D Progress 50
Keratitis - Recent Pipeline Updates 51
Keratitis - Dormant Projects 64
Keratitis - Product Development Milestones 65
Featured News & Press Releases…

For more information open Keratitis - Pipeline Review, H1 2015.

SKU: GMDHC6626IDB

Original Article: Keratitis - Pipeline Review, H1 2015

NEXT ARTICLE

More From BioPortfolio on "Keratitis - Pipeline Review, H1 2015"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...